In this issue:
- Metabolic outcomes with time-restricted eating
- Adverse maternal and neonatal outcomes with low/high gestational weight gain
- Challenges to culturally-responsive type 2 diabetes care in Australia
- Movement behaviours in adults with type 2 diabetes
- Multimodal mobile health interventions for cardiovascular risk factors in diabetes
- Gestational weight gain after GLP-1 receptor agonist discontinuation
- An AI-powered diabetes prevention programme vs. human coaching
- ATTAIN-2: orforglipron for obesity with type 2 diabetes
- POInT: high-dose, oral insulin in children at risk of type 1 diabetes
- Cancer risks and mortality with GLP-1 receptor agonists and SGLT-2 inhibitors
Please login below to download this issue (PDF)